Grifols, S.A. (BME:GRF)
Spain · Delayed Price · Currency is EUR 10.17
+0.07 (0.64%)
Aug 7, 2026, 1:12 PM CET
Grifols Market Cap
Grifols has a market cap or net worth of €6.03 billion as of August 7, 2026. Its market cap has decreased by -22.54% in one year.
Market Cap
6.03B
Enterprise Value
17.28B
Revenue
7.42B
Ranking
n/a
PE Ratio
15.31
Stock Price
€10.17
ChartMarket Cap Chart
Since May 18, 2006, Grifols's market cap has increased from 729.00M to 6.03B, an increase of 727.02%. That is a compound annual growth rate of 11.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 6.03B | -7.78% |
| Dec 31, 2025 | 6.54B | 15.08% |
| Dec 31, 2024 | 5.68B | -38.46% |
| Dec 29, 2023 | 9.23B | 40.77% |
| Dec 30, 2022 | 6.56B | -32.97% |
| Dec 30, 2021 | 9.78B | -30.92% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Laboratorios Farmaceuticos Rovi | 3.00B |
| Almirall | 2.39B |
| Faes Farma | 1.40B |
| Pharma Mar | 1.37B |
| Clínica Baviera | 974.81M |
| Oryzon Genomics | 240.15M |
| Prim, S.A. | 227.98M |
| Laboratorio Reig Jofre | 223.07M |